ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 93 filers reported holding ENZO BIOCHEM INC in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $485,000 | +134.3% | 106,449 | +136.1% | 0.00% | – |
| Q4 2015 | $207,000 | +567.7% | 45,081 | +546.9% | 0.00% | – |
| Q4 2014 | $31,000 | -96.0% | 6,969 | -95.3% | 0.00% | -100.0% |
| Q3 2014 | $770,000 | +12.2% | 149,518 | +4.9% | 0.00% | 0.0% |
| Q2 2014 | $686,000 | +1272.0% | 142,549 | +618.9% | 0.00% | – |
| Q3 2013 | $50,000 | +22.0% | 19,830 | 0.0% | 0.00% | – |
| Q2 2013 | $41,000 | – | 19,830 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARBERT FUND ADVISORS, INC. | 5,620,681 | $20,234,000 | 30.10% |
| Evermore Global Advisors, LLC | 4,007,851 | $14,428,000 | 3.48% |
| Fondren Management LP | 355,000 | $1,278,000 | 1.06% |
| CORRADO ADVISORS, LLC | 196,309 | $707,000 | 0.64% |
| MARATHON CAPITAL MANAGEMENT | 193,580 | $697,000 | 0.28% |
| KEMPNER CAPITAL MANAGEMENT INC. | 95,476 | $344,000 | 0.23% |
| EAM Investors, LLC | 203,962 | $734,000 | 0.19% |
| Ariel Investments | 1,026,313 | $3,695,000 | 0.05% |
| HighVista Strategies LLC | 19,500 | $70,000 | 0.05% |
| Paradigm Financial Partners, LLC | 17,175 | $60,000 | 0.03% |